Breast Reconstruction Market

Breast Reconstruction Market is Expected to be Flourished by Incorporation of 3D Printing Technology

by

The breast reconstruction market includes reconstruction procedures and products that are used to recreate a natural, symmetric shape and appearance of the breast after mastectomy or breast cancer surgery. The procedures involve using either breast implants or body’s own tissue to rebuild the breast shape. Breast implants involve using saline or silicone gel-filled implants to reconstruct the breasts. On the other hand, tissue flap procedures use body’s own tissue to reconstruct the breasts either from abdomen, back or thighs. 3D printing technology enables the production of exact replicas of affected breasts using medical imaging scans for precise reconstructive surgeries. The incorporation of 3D printing is expected to enhance the reconstructive outcomes and shorten surgery duration.

The global breast reconstruction market is estimated to be valued at US$ 901.3 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

Increasing prevalence of breast cancer cases globally is one of the major drivers of breast reconstruction market. According to the World Health Organization (WHO), breast cancer is the most common cancer in women worldwide, with an estimated 2.3 million new breast cancer cases diagnosed in 2020. The incorporation of 3D printing technology is expected to flourish the breast reconstruction market by significantly improving reconstructive outcomes. 3D printed replicas of affected breasts help surgeons precisely plan and perform reconstructive surgeries in shorter duration reducing risks and hospital stay. Advancements in 3D printing tools such as medical imaging integration enable realistic simulation of reconstructive procedures prior to surgery.

Segment Analysis

The global breast reconstruction market is segmented based on the product type, procedure, end-user and geography. Based on the product type, the market is segmented into breast implants, tissue expanders and acellular dermal matrix. Among these, the breast implants segment is dominating and is projected to continue its dominance during the forecast period. This is owing to the increasing prevalence of breast cancer and rising cosmetic breast surgeries.

PEST Analysis

Political: Government regulations related to breast reconstruction surgeries and medical products are influencing the market growth. Various awareness campaigns by governments and NGOs are raising awareness about breast cancer and reconstruction options.
Economic: Rising healthcare expenditure, increasing disposable incomes and growing medical tourism are fueling the market growth. The high costs associated with reconstruction procedures may hinder the market to an extent.
Social: Changing social perceptions, growing social acceptance of cosmetic procedures and rising participation of women in social activities are propelling the market growth.
Technological: Ongoing R&D activities are resulting in development of innovative breast reconstruction products and minimally invasive techniques. 3D printing technology and stem cell therapy based options are providing new opportunities.

Key Takeaways

The Global Breast Reconstruction Market Size is expected to witness high growth over the forecast period driven by the rising prevalence of breast cancer worldwide. Regionally, North America is projected to dominate the market during the forecast period owing to the rising healthcare expenditure, availability of advanced treatment options and growing public awareness in the region.

Key players operating in the breast reconstruction market are Mentor Medical Systems B.V. (Johnson & Johnson), Allergan, Inc. (AbbVie), Sientra, Inc., Ideal Implant Incorporated, Establishment Labs, POLYTECH Health & Aesthetics GmbH, RTI Surgical, Sebbin, Integra LifeSciences, GC Aesthetics. Mentor Medical Systems holds a prominent share in the breast implants segment with its wide product portfolio. Allergan is a leading player in the tissue expanders segment.

 

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it